Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPRG.L Regulatory News (PRG)

  • There is currently no data for PRG

Non-Board Appointments

9 May 2005 07:01

Premier Research Group09 May 2005 For Immediate Release 9 May 2005 Premier Research appoints Anthony Orlando and Bruce C Stouch to New Senior Management Positions Premier Research Group plc (AIM: PRG) ("Premier Research", "Company" or "Group"), the international pharmaceutical services group today announces theappointment of -- Anthony Orlando, Ph.D and Bruce C Stouch Ph.D to seniormanagement positions in Premier Research. Dr Anthony Orlando, Ph.D has joined the US Operations of Premier Research Groupplc in the new position of Executive Director, Data Operations. Dr. Orlandobrings an exceptional background in Biostatistics and Data Management over thepast thirty years including key roles in pharmaceutical companies, the NationalCenter for Toxicological Research/FDA and at major contract researchorganizations. He most recently joined the company from his position as VicePresident, Biostatistics at SFBC New Drug Services. Dr. Orlando holds a Ph.D. inBiometry from Yale University, has co-authored many papers in his area ofexpertise and has supported several drug NDAs for a variety of indications. Hewill be responsible for US data management, programming and biostatistics forPremier Research. In addition to Dr. Orlando's position, Premier Research also is pleased toannounce that Bruce C. Stouch, Ph.D. has taken the international position ofChief Scientific Officer for the company. In Dr. Stouch's new role, he will leadthe company's efforts supporting expert FDA/statistical clinical design andanalysis capabilities. He will also establish and expand the company's newinitiative into Bayesian monitoring and analysis methods. Dr. Stouch has over15 years of biostatistics experience in pharmaceuticals. For 12 years, Dr. Stouch held position of Director of Biostatistics andScientific Data Management at Johnson & Johnson in Exton, PA, where he wasresponsible for strategic development and implementation of pharmacoeconomicmodels of emerging technologies in several therapeutic areas. Dr. Stouch hasbeen involved in over two dozen publications and acknowledgements. He holds anacademic appointment at the Philadelphia College of Medicine as Director,Biostatistics and Clinical Epidemiology. Dr. Stouch received his Ph.D. inBiostatistics and Epidemiology from Jefferson Medical College in 1997 through aprogram sponsored by Johnson & Johnson, and trained in post-graduate studiesfrom Temple University, Jefferson Medical College, and Harvard School of PublicHealth. Dr Simon Yaxley, CEO of Premier Research Group plc, commented: "We are proud andpleased to announce the significant strengthening of our data management andstatistics capabilities in the US Operations, we also believe that Tony andBruce place our company at the forefront of trial design, monitoring andanalysis methods worldwide." About Premier Research Premier Research Group plc is a contract research organisation focused on thedesign, management and reporting of all phases of clinical trials on behalf ofpharmaceutical and biotechnology companies. The Company specialises in oncology,central nervous system, paediatrics and anti-infectives. For Further information, please contact: Premier Research Group Plc Tel: 01344 458 311Dr Simon Yaxley, Chief Executive Buchanan Communications Tel: 020 7466 5000Lisa Baderoon/Diane Stewart/Rebecca Skye Dietrich This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
25th Mar 20138:00 amRNSDirectorate Change
6th Mar 20137:00 amRNSLemphane, Operational update
31st Jan 20137:40 amRNSLemphane operational update
14th Jan 20137:00 amRNSScoping study and drilling contracts
8th Jan 20137:00 amRNSMemorandum of Understanding
19th Dec 20128:46 amRNSDirectorate Change
3rd Dec 201212:36 pmRNSOperational Update
25th Sep 20127:00 amRNSDirectorate Change
19th Sep 20127:00 amRNSHalf Yearly Report
4th Sep 20127:00 amRNSOperational Update - Motete Dyke
28th Aug 20127:00 amRNSMotete update
24th Jul 20127:00 amRNSFurther Bulk Sample Results, Motete Dyke project
9th Jul 201212:11 pmRNSResult of AGM
4th Jul 20128:47 amRNSPreliminary Bulk Sample Results
8th Jun 201210:49 amRNSHolding(s) in Company
7th Jun 20121:39 pmRNSDirector/PDMR Shareholding
6th Jun 201211:08 amRNSLicence Extension Awarded
1st Jun 20127:00 amRNSAnnual Financial Report
31st May 201210:28 amRNSTotal Voting Rights
26th Apr 20127:00 amRNSAcquisition of remaining interest in IDC
13th Apr 20127:00 amRNSOperational Update at Motete Dyke
12th Apr 20122:38 pmRNSOperational Update
11th Apr 20127:00 amRNSFurther bulk sampling results from Lemphane
29th Mar 20127:00 amRNSCompletion of Micro-Diamond Recovery at Motete
26th Mar 20127:00 amRNSLaunch of website
19th Mar 201210:54 amRNSHolding(s) in Company
15th Mar 201210:55 amRNSHolding(s) in Company
1st Mar 20127:00 amRNSTotal Voting Rights
24th Feb 20127:00 amRNSNew Exploration Targets Identified in Lesotho
16th Feb 20127:00 amRNSFirst Large Diamonds Recovered from Lemphane
7th Feb 20127:00 amRNSFurther positive micro-diamond results from Motete
26th Jan 201212:25 pmRNSFundraising and Issue of Equity
18th Jan 20128:45 amRNSDirectorate Change
16th Jan 20127:00 amRNSDiamond grade and volumetric estimate at Motete
9th Jan 20127:00 amRNSFurther results from large micro-diamond sample
4th Jan 20127:00 amRNSPositive results from first micro-diamond sample
7th Dec 20117:00 amRNSAppointment of Nominated Adviser
1st Dec 20117:00 amRNSAward of License
7th Nov 20117:00 amRNSCommencement of bulk sampling at Lemphane, Lesotho
27th Sep 20117:00 amRNSInterim Results
31st Aug 20112:44 pmRNSUpdate on Operations and Exploration
29th Jul 20113:44 pmRNSTotal Voting Rights
26th Jul 20111:47 pmRNSDiamond and Gold Sale
26th Jul 201110:46 amRNSAward of Licence
14th Jul 20117:00 amRNSMineral Chemistry Results
21st Jun 201111:57 amRNSStatement re Further Directorate Change
21st Jun 20117:00 amRNSDirectorate Change
18th May 20117:00 amRNSCompletion of acquisiton of IDC
12th May 201111:29 amRNSResult of AGM
11th May 201111:48 amRNSDirector Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.